AstraZeneca appoints new vice-president

Updated: 2010-12-17 14:21

By Liu Jie (

Twitter Facebook Myspace Yahoo! Linkedin Mixx

AstraZeneca appoints new vice-president

International pharmaceutical giant AstraZeneca has announced the appointment of Steve Yang as vice-president and head of research and development (R&D) for its Asia and emerging markets business, which is to take effect on Jan 6, 2011.

Related readings:
AstraZeneca appoints new vice-president AstraZeneca 'mulling partnerships'
AstraZeneca appoints new vice-president AstraZeneca weathers global financial downturn
AstraZeneca appoints new vice-president AstraZeneca steps up presence in China

Yang was most recently vice-president and head of Asia R&D for Pfizer. The appointment is a move for AstraZeneca to strengthen its R&D capabilities at the most promising marketplaces.

Yang will be based in Shanghai and will report to Martin Mackay, R&D president of AstraZeneca.

"I am delighted that Steve is joining AstraZeneca. Yang has a rare and wide experience in Asia and emerging markets. He will greatly enhance the implementation of our strategy for R&D to deliver meaningful medicines for patients across both Asia and other important emerging markets," said Mackay.


Ear We Go

China and the world set to embrace the merciful, peaceful year of rabbit

Preview of the coming issue
Carrefour finds the going tough in China
Maid to Order

European Edition


Mysteries written in blood

Historical records and Caucasian features of locals suggest link with Roman Empire.

Winning Charm

Coastal Yantai banks on little things that matter to grow

New rules to hit property market

The State Council launched a new round of measures to rein in property prices.

Top 10 of 2010
China Daily in Europe
The Confucius connection